Will family studies return to prominence in human genetics and genomics? Rare variants and linkage analysis of complex traits
Tóm tắt
A major focus of modern human genetics has been the search for genetic variations that contribute to human disease. These studies originated in families and used linkage methods as a primary analytical tool. With continued technical improvements, these family-based linkage studies have been very powerful in identifying genes contributing to monogenic disorders. When these methods were applied to disorders with complex, non-Mendelian patterns of inheritance they largely failed. The development of effective capabilities for Genome Wide Association Studies (GWAS) relegated family-based studies to a peripheral role in human genetics research. Despite the remarkable record of GWAS discoveries, common variations identified in GWAS account for a limited (frequently less than 10%) proportion of the heritable risk of qualitative traits or variance of quantitative traits. Next generation sequencing is facilitating a re-examination of family-based methods with surprising and intriguing results. We propose that rare variants of large effect underlie many linkage peaks, including complex quantitative phenotypes, and review the issues underlying this proposed basis for complex traits.
Tài liệu tham khảo
Alkuraya FS (2010) Homozygosity mapping: one more tool in the clinical geneticist’s toolbox. Genet. Med. 12:236–239. Review.
Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, et al. (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet. 38:644–651.
Bergman RN, Zaccaro DJ, Watanabe RM, Haffner SM, Saad MF, et al. (2003) Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes. 52:2168–2174.
Bodmer W and Bonilla C. (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40:695–701. Review.
Botstein D and Risch N. (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33: 228–237. Review.
Bowden DW, An SS, Palmer ND, Brown WM, Norris JM, et al. (2010) Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study. Hum. Mol. Genet. 19:4112–4120.
Cooper DN, Chen JM, Ball EV, Howells K, Mort M, et al. (2010) Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum. Mutat. 31:631–655. Review.
Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 329:841–845.
Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, et al. (1999) Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl. Acad. Sci. USA. 96:2198–2203.
Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat. Genet. 38:320–323.
Guan W, Pluzhnikov A, Cox NJ, Boehnke M; International Type 2 Diabetes Linkage Analysis Consortium. (2008) Meta-analysis of 23 type 2 diabetes linkage studies from the International Type 2 Diabetes Linkage Analysis Consortium. Hum. Hered. 66(1):35–49. Erratum in: Hum. Hered. 66:237.
Guo X, Saad MF, Langefeld CD, Williams AH, Cui J, et al. (2006) Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: the IRAS family study. Diabetes. 55:1723–1730.
Hauser ER, Watanabe RM, Duren WL, Bass MP, Langefeld CD, et al. (2004) Ordered subset analysis in genetic linkage mapping of complex traits. Genet. Epidemiol. 27:53–63.
Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, et al. (2010) Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis. 208:412–420.
Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, et al. (2003) Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann. Epidemiol. 13:211–217.
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 411:599–603.
Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, et al. (2010) Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 42:684–687.
Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science. 308:385–389.
Lakoski SG, Lagace TA, Cohen JC, Horton JD, and Hobbs HH. (2009) Genetic and metabolic determinants of plasma PCSK9 levels. J. Clin. Endocrinol. Metab. 94:2537–2543.
Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, et al. (2008) Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes. 57:1108–1114.
Lewis JP, Palmer ND, Hicks PJ, Sale MM, Langefeld CD, et al. (2008) Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes. 57:2220–2225.
Manolio TA. (2010a) Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363:166–176. Review.
Manolio TA. (2010b) Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363:166–176. Review.
McCarthy MI. (2010) Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 363:2339–2350. Review.
McDonough CW, Bostrom MA, Lu L, Hicks PJ, Langefeld CD, et al. (2009) Genetic analysis of diabetic nephropathy on chromosome 18 in African Americans: linkage analysis and dense SNP mapping. Hum. Genet. 126:805–817
Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, et al. (2008) Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes. N. Eng. J. Med. 359:2208–2219.
de Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, et al. (2011) Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 34:121–125
Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, et al. (2010) Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363:2220–2227.
Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, et al. (2010b) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42:790–793.
Ng SB, Nickerson DA, Bamshad MJ, and Shendure J. (2010a) Massively parallel sequencing and rare disease. Hum. Mol. Genet. 19:R119–124.
Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, et al. (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 461:272–276.
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 411:603–606.
Palmer ND, Langefeld CD, Campbell JK, Williams AH, Saad M, et al. (2006) Genetic mapping of disposition index and acute insulin response loci on chromosome 11q. The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 55:911–918.
Palmer ND, Mychaleckyj JC, Langefeld CD, Ziegler JT, Williams AH, et al. (2009) Evaluation of DLG2 as a positional candidate for disposition index in African-Americans from the IRAS family study. Diabetes Res. Clin. Pract. 87:69–76.
Parson W, Kraft HG, Niederstätter H, Lingenhel AW, Köchl S, et al. (2004) A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a). Hum. Mutat. 24:474–480.
Pollin TI, Tanner K, O’connell JR, Ott SH, Damcott CM, et al. (2005) Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes. 54:268–274.
Prokopenko I, Zeggini E, Hanson RL, Mitchell BD, Rayner NW, et al. (2009) Linkage disequilibrium mapping of the replicated type 2 diabetes linkage signal on chromosome 1q. Diabetes. 58:1704–1709.
Rich SS, Bowden DW, Haffner SM, Norris JM, Saad MF, et al. (2004) Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 53:1866–1875.
Rios J, Stein E, Shendure J, Hobbs HH, and Cohen JC. (2010) Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia. Hum. Mol. Genet. 19:4313–8.
Roberson ED, and Bowcock AM. (2010) Psoriasis genetics: breaking the barrier. Trends Genet. 26:415–423. Review.
Romeo S, Pennacchio LA, Fu Y, Boerwinkle E, Tybjaerg-Hansen A, et al. (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 39:513–516.
Romeo S, Yin W, Kozlitina J, Pennacchio LA, Boerwinkle E, et al. (2009) Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 119:70–79.
Smith EM, Zhang Y, Baye TM, Gawrieh S, Cole R, et al. (2010) INSIG1 influences obesity-related hypertriglyceridemia in humans. J. Lipid Res. 51:701–708.
Sobreira NL, Cirulli ET, Avramopoulos D, Wohler E, Oswald GL, et al. (2010) Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet. 6:e1000991.
Sutton BS, Langefeld CD, Campbell JK, Haffner SM, Norris JM, et al. (2006) Genetic mapping of a 17q chromosomal region linked to obesity phenotypes in the IRAS family study. Int. J. Obes (Lond). 30:1433–1441.
Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, et al. (2002) Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 418:426–430.
Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. (2010) Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42:565–569.